Enhanced hepatic drug clearance in patients with cystic fibrosis (Q44424763)

2 December 2017

title

Enhanced hepatic drug clearance in patients with cystic fibrosis (English)

1 reference

2 December 2017

0 references

Kearns GL

1

1 reference

2 December 2017

Mallory GB Jr

series ordinal

2

1 reference

2 December 2017

Crom WR

series ordinal

3

1 reference

2 December 2017

Evans WE

series ordinal

4

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 December 1990

1 reference

The Journal of Pediatrics

2 December 2017

published in

1 reference

2 December 2017

volume

117

1 reference

2 December 2017

issue

6

1 reference

2 December 2017

page(s)

972-979

1 reference

Dosing implications of altered gentamicin disposition in patients with cystic fibrosis

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Disposition of tobramycin in patients with cystic fibrosis: a prospective controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Cloxacillin absorption and disposition in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Theophylline disposition in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Ceftazidime disposition in acute and stable cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Pharmacokinetics of Methicillin in Patients with Cystic Fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Cystic fibrosis: enhanced theophylline metabolism may be linked to the disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Increased nonrenal clearance and increased diuretic efficiency of furosemide in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Introduction to pharmacokinetics: aminoglycosides in cystic fibrosis as a prototype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

The nephropathy of cystic fibrosis: a human model of chronic nephrotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Liver scans in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Liver disease and common-bile-duct stenosis in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

The effects of age on alkaline phosphatase and other serologic liver function tests in normal subjects and patients with cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Serum alkaline phosphatase in cystic fibrosis. Interpretation of elevated values based on electrophoretic isoenzyme analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Hepatic drug clearance in children with leukemia: changes in clearance of model substrates during remission-induction therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Simultaneous analysis of antipyrine and lorazepam by high-performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

AUTOMOD: a polyalgorithm for an integrated analysis of linear pharmacokinetic models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

An Algorithm for Least-Squares Estimation of Nonlinear Parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Altered Hepatic Blood Flow and Drug Disposition1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Influence of phenobarbital on factors responsible for hepatic clearance of indocyanine green in the rat: relative contributions of induction and altered liver blood flow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

The antipyrine test in clinical pharmacology: Conceptions and misconceptions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Factors influencing antipyrine elimination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Depression of Aminopyrine Metabolism by Influenza Vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Pharmacokinetics and Bioavailability of Intravenous, Intramuscular, and Oral Lorazepam in Humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Effect of heparin administration on plasma binding of benzodiazepines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Effects of aging and liver disease on disposition of lorazepam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Guide to drug dosage in hepatic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Drug metabolism in extrahepatic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Pulmonary Disease and Drug Kinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Hepatic changes in young infants with cystic fibrosis: Possible relation to focal biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Effect of taurolithocholate on in vivo sulfation and glucuronidation of acetaminophen in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

High incidence of poor sulfoxidation in patients with primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Simultaneous administration of multiple model substrates to assess hepatic drug clearance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Monogenic control of variations in antipyrine metabolite formation. New polymorphism of hepatic drug oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Genetic variation in rates of antipyrine metabolite formation: a study in uninduced twins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Polymorphism of theophylline metabolism in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Development of multiple activities of UDP-glucuronyltransferase in human liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Hepatic clearances of antipyrine, indocyanine green, and galactose in normal subjects and in patients with chronic liver diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Clinical Pharmacokinetics of Frusemide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Lorazepam pharmacodynamics and pharmacokinetics in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Disposition of lorazepam in human beings: enterohepatic recirculation and first-pass effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

TheAhLocus: Genetic Regulation of the Metabolism of Carcinogens, Drugs, and Other Environmental Chemicals by Cytochrome P-450-Mediated Monooxygenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

The P450 gene superfamily: recommended nomenclature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Cystic fibrosis: a casualty of "detoxification"?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Morphological findings in the liver of children with cystic fibrosis: a light and electron microscopical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

Evidence for a mitochondrial lesion in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980149-0

10.1016/S0022-3476(05)80149-0

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference